Mizuho has downgraded STAAR Surgical (NASDAQ:STAA) to neutral from outperform, citing a slowdown in sales of the company's Implantable Collamer Lenses, or ICLs, in China. The investment bank said ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback